Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis

• Yue Song,
• Fei Zhou,
• Feng Du,
• Ziyan Wang,
• Liyun Bai,
• Yifang Yao,
• Limin Liu,
• Xiao Ma,
• Suning Chen,
• Depei Wu,
• Xuefeng He

Affiliations

Yue Song

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University

Fei Zhou

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University

Feng Du

Department of hematology, Soochow Hopes Hematonosis Hospital

Ziyan Wang

Department of hematology, Soochow Hopes Hematonosis Hospital

Liyun Bai

Department of hematology, Soochow Hopes Hematonosis Hospital

Yifang Yao

Department of hematology, Soochow Hopes Hematonosis Hospital

Limin Liu

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University

Xiao Ma

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University

Suning Chen

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University

Depei Wu

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University

Xuefeng He

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University